Caitong International Asset Management’s NewAmsterdam Pharma NAMS Stock Holding History

Caitong International Asset Management’s Portfolio NAMS Stock Details NAMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$328K	Buy	9,682 +5,906	+156%	+$195K	0.05%	313
2026 Q1	$121K	Buy	3,776 +3,753	+16,317%	+$122K	0.02%	527
2025 Q4	$807	Buy	+23	New	+$837	﹤0.01%	1398
2025 Q3	–	Sell	-595	Closed	-$10.8K	–	2315
2025 Q2	$10.8K	Buy	595 +463	+351%	+$8.45K	0.01%	695
2025 Q1	$2.7K	Sell	132 -88	-40%	-$1.96K	﹤0.01%	1230
2024 Q4	$5.65K	Buy	+220	New	+$4.67K	0.01%	1027

Other funds holding NAMS

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Caitong International Asset Management's NAMS Position: Q2 2026 in Review

Caitong International Asset Management increased its NewAmsterdam Pharma (NAMS) stake by 156% in Q2 2026, buying an estimated $195K and bringing the position to 9,682 shares worth $328K. The position accounts for 0.05% of the portfolio, ranked #313.

Caitong International Asset Management first reported a position in NAMS in Q4 2024 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

Caitong International Asset Management held 9,682 shares of NewAmsterdam Pharma worth $328K as of Q2 2026.
Caitong International Asset Management bought 5,906 NewAmsterdam Pharma shares in Q2 2026, an estimated $195K.
NewAmsterdam Pharma made up 0.05% of Caitong International Asset Management's portfolio in Q2 2026, its #313 holding.
Caitong International Asset Management first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 6 quarters since.
194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.